Skip to main content
BNTX logo

BioNTech SE

BNTXNASDAQHealthcareBiotechnology

$90.20Today:- (-)1Y −14.16%

As of Oct 15, 2026 close

Market cap
$22.85B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$79.52$124.00
Volume (live)
-
Avg. volume (3M)
952.17K

BioNTech SE (BNTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), BioNTech SE reported total assets of EUR 21.99B and total liabilities of EUR 2.76B. Shareholders' equity was EUR 19.22B, down 1.0% from EUR 19.41B a year earlier. Total debt stood at EUR 37.10M against EUR 13.74B in cash and short-term investments, a net cash position of EUR 13.70B. That puts debt-to-equity at 0.00, compared with 0.01 a year earlier.

BioNTech SE Balance Sheet Analysis

Values in billions EUR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for BioNTech SE (BNTX) - Annual data in billions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Mar 2020Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents7.689.7611.6613.881.691.210.520.410.17
Short-Term Investments6.076.084.890.190.380.140.000.000.00
Cash & Short-Term Investments13.7415.8416.5514.062.071.350.520.410.17
Accounts Receivable0.921.462.347.1512.380.170.010.030.00
Inventory0.110.280.360.440.500.060.010.010.00
Other Current Assets0.230.260.280.270.110.090.020.010.01
Total Current Assets16.1518.8019.5321.9215.071.670.560.450.19
Non-Current Assets
Property, Plant & Equipment (Net)1.291.180.970.820.520.330.150.120.10
Long-Term Investments2.551.251.180.080.020.000.000.000.00
Goodwill0.370.380.360.060.060.050.000.000.00
Intangible Assets1.610.790.800.150.140.100.080.090.08
Other Non-Current Assets0.020.120.080.240.010.010.000.000.00
Total Non-Current Assets5.843.733.481.360.760.650.240.200.19
Total Assets21.9922.5323.0123.2815.832.320.800.650.37
Current Liabilities
Accounts Payable0.530.430.350.200.160.100.020.040.05
Short-Term Debt0.010.040.030.040.130.000.010.000.00
Current Portion of Long-Term Debt0.01---0.100.00---
Accrued Liabilities0.150.140.270.370.11----
Deferred Revenue0.750.290.350.100.190.390.000.070.08
Other Current Liabilities0.661.620.812.241.440.100.110.080.11
Total Current Liabilities2.142.522.072.953.480.610.140.130.16
Non-Current Liabilities
Long-Term Debt0.030.210.190.000.170.150.070.000.05
Deferred Tax Liabilities0.080.040.040.010.070.000.00-0.21-0.21
Other Non-Current Liabilities0.410.380.060.100.210.040.100.000.21
Total Non-Current Liabilities0.620.600.690.270.460.340.170.260.26
Total Liabilities2.763.122.763.223.940.950.300.390.42
Stockholders' Equity
Common Stock0.260.250.250.250.250.250.230.190.17
Retained Earnings17.9619.1019.7618.839.88-0.41-0.42-0.25-0.20
Accumulated Other Comprehensive Income-1.46-1.33-0.98-0.850.091.540.690.32-0.02
Treasury Stock0.010.010.010.010.00----
Additional Paid-in Capital2.471.401.221.831.670.00-0.010.340.01
Minority Interest0.000.000.000.000.000.000.000.000.00
Shares Outstanding0.250.240.240.240.24----
Total Stockholders' Equity19.2219.4120.2520.0611.891.370.490.27-0.05
Total Liabilities & Equity21.9922.5323.0123.2815.832.320.800.650.37

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioNTech SE Balance Sheet

How much debt does BioNTech SE have?

BioNTech SE had total debt of EUR 37.10M as of Dec 31, 2025, against EUR 13.74B in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was EUR 254.20M a year earlier.

What are BioNTech SE's total assets?

BioNTech SE reported total assets of EUR 21.99B as of Dec 31, 2025, down 2.4% from EUR 22.53B a year earlier. Total liabilities were EUR 2.76B.

What is BioNTech SE's shareholders' equity?

BioNTech SE's shareholders' equity was EUR 19.22B as of Dec 31, 2025, or about EUR 76.49 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition